Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NRC HEALTHNRC · Entity 5534 | SVP Finance, CFO, Treas & Secy | February 24, 2023 | February 28, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NRC HEALTH
Report date February 24, 2023 · Filed February 28, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,384 |
Ending reported balance
After 2023-02-28 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2023-02-24 · Sale · Disposed 7,156 · Balance 10,140 F1: The price in Column 4 is a weighted average price. The prices actually ranged from $45.55 to $45.95, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2), and (3) of this Form 4. Row 2 · 2023-02-27 · Sale · Disposed 2,437 · Balance 7,703 F2: The price in Column 4 is a weighted average price. The prices actually ranged from $45.00 to $45.74, inclusive. Row 3 · 2023-02-28 · Sale · Disposed 2,319 · Balance 5,384 F3: The price in Column 4 is a weighted average price. The prices actually ranged from $45.13 to $45.62, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price in Column 4 is a weighted average price. The prices actually ranged from $45.55 to $45.95, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2), and (3) of this Form 4.
F2: The price in Column 4 is a weighted average price. The prices actually ranged from $45.00 to $45.74, inclusive.
F3: The price in Column 4 is a weighted average price. The prices actually ranged from $45.13 to $45.62, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2023 Filed Feb 28, 2023 22:16 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,319 | $45.34 | $105,132.56 |
DisclosureSEC source: 0001567619-23-003958 · doc1.xml · nonDerivative · entry 3 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,384 F3 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $45.13 to $45.62, inclusive. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 22:16 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,437 | $45.51 | $110,915.42 |
DisclosureSEC source: 0001567619-23-003958 · doc1.xml · nonDerivative · entry 2 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,703 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $45.00 to $45.74, inclusive. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 22:16 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 7,156 | $45.84 | $328,048.21 |
DisclosureSEC source: 0001567619-23-003958 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,140 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $45.55 to $45.95, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2), and (3) of this Form 4. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 22:45 UTC | NRC HEALTH NRC · Entity 5534 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,981 | $0.00 Strike: $38.93 | $0.00 |
DisclosureSEC source: 0001567619-23-000523 · doc1.xml · derivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,981 Underlying: Common Stock · 10,981 shares Expires 2033-01-04 F1 · derivative.exercise_date: This option becomes fully exercisable on January 4, 2028. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 22:04 UTC | NRC HEALTH NRC · Entity 5534 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,118 | $0.00 Strike: $42.25 | $0.00 |
DisclosureSEC source: 0001567619-22-000747 · doc1.xml · derivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,118 Underlying: Common Stock · 10,118 shares Expires 2032-01-04 F1 · derivative.exercise_date: This option becomes fully exercisable on January 4, 2027. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 20:13 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,000 | $53.16 | $265,815.00 |
DisclosureSEC source: 0001567619-21-015064 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,296 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $53.00 to $53.44, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within this range. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:36 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 19,313 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001567619-21-006960 · doc1.xml · derivative · entry 7 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,313 shares Expires 2025-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option became fully exercisable on January 6, 2020. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:36 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,334 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0001567619-21-006960 · doc1.xml · derivative · entry 6 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,334 shares Expires 2024-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became fully exercisable on January 7, 2019. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:36 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 12,735 | $45.55 | $580,079.25 |
DisclosureSEC source: 0001567619-21-006960 · doc1.xml · nonDerivative · entry 5 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,296 Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:36 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 19,313 | $13.17 | $254,352.21 |
DisclosureSEC source: 0001567619-21-006960 · doc1.xml · nonDerivative · entry 4 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:36 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 5,334 | $18.80 | $100,279.20 |
DisclosureSEC source: 0001567619-21-006960 · doc1.xml · nonDerivative · entry 3 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:25 UTC | NRC HEALTH NRC · Entity 5534 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,960 | $0.00 Strike: $42.92 | $0.00 |
DisclosureSEC source: 0001567619-21-000727 · doc1.xml · derivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,960 Underlying: Common Stock · 9,960 shares Expires 2031-01-05 F1 · derivative.exercise_date: This option becomes fully exercisable on January 5, 2026. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 22:01 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,088 | $0.00 Strike: $14.50 | $0.00 |
DisclosureSEC source: 0001567619-20-011915 · doc1.xml · derivative · entry 5 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,088 shares Expires 2023-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became fully exercisable on January 7, 2018. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 22:01 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 9,704 | $57.22 | $555,262.88 |
DisclosureSEC source: 0001567619-20-011915 · doc1.xml · nonDerivative · entry 4 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,384 Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 22:01 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 20,088 | $14.50 | $291,276.00 |
DisclosureSEC source: 0001567619-20-011915 · doc1.xml · nonDerivative · entry 3 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 22:01 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 6,718 | $58.62 | $393,827.97 |
DisclosureSEC source: 0001567619-20-011915 · doc1.xml · nonDerivative · entry 2 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $58.00 to $58.93, inclusive. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 22:01 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 6,858 | $57.28 | $392,846.81 |
DisclosureSEC source: 0001567619-20-011915 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,718 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $57.00 to $57.80, inclusive. The reporting person has provided the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 21:54 UTC | NRC HEALTH NRC · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 6,497 | $0.00 Strike: $65.80 | $0.00 |
DisclosureSEC source: 0001567619-20-000715 · doc1.xml · derivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,497 Underlying: Common Stock · 6,497 shares Expires 2030-01-03 F1 · derivative.exercise_date: This option becomes fully exercisable on January 3, 2025. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 16:21 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,902 | $62.83 | $182,337.59 |
DisclosureSEC source: 0001567619-19-018032 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,576 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $62.30 to $63.165. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 18:42 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,177 | $64.34 | $268,758.20 |
DisclosureSEC source: 0001567619-19-017985 · doc1.xml · nonDerivative · entry 2 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,478 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $64.00 to $64.55. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 18:42 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,937 | $63.43 | $186,296.55 |
DisclosureSEC source: 0001567619-19-017985 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,655 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $63.00 to $63.60. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 16:47 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 26,403 | $0.00 Strike: $10.75 | $0.00 |
DisclosureSEC source: 0001567619-19-017942 · doc1.xml · derivative · entry 3 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,403 shares Expires 2022-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option became fully exercisable on January 5, 2017. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 16:47 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 12,827 | $64.05 | $821,569.35 |
DisclosureSEC source: 0001567619-19-017942 · doc1.xml · nonDerivative · entry 2 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,592 Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 16:47 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 26,403 | $10.75 | $283,832.25 |
DisclosureSEC source: 0001567619-19-017942 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:29 UTC | NRC HEALTH NRC · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 11,162 | $0.00 Strike: $38.30 | $0.00 |
DisclosureSEC source: 0001567619-19-000709 · doc1.xml · derivative · entry 9 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,162 Underlying: Common Stock · 11,162 shares Expires 2029-01-03 F8 · derivative.exercise_date: This option becomes fully exercisable on January 3, 2024. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 21:47 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-003570 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,016 Read SEC document |
| September 24, 2018 Filed Mar 25, 2021 20:36 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 300 | $39.06 | $11,717.49 |
DisclosureSEC source: 0001567619-21-006960 · doc1.xml · nonDerivative · entry 2 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,384 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $39.025 to $39.075, inclusive. Read SEC document |
| September 24, 2018 Filed Mar 25, 2021 20:36 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 3,700 | $38.23 | $141,445.82 |
DisclosureSEC source: 0001567619-21-006960 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,684 F1 · price: The price in Column 4 is a weighted average. The prices actually ranged from $38.00 to $38.70, inclusive. The reporting person has provided the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| September 19, 2018 Filed Sep 19, 2018 21:54 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 735 | $38.52 | $28,313.52 |
DisclosureSEC source: 0001567619-18-002900 · doc1.xml · nonDerivative · entry 2 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,316 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $38.50 to $38.55. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| September 19, 2018 Filed Sep 25, 2018 20:06 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 735 | $38.52 | $28,313.52 |
DisclosureSEC source: 0001567619-18-003090 · doc1.xml · nonDerivative · entry 2 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,316 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $38.50 to $38.55. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| September 18, 2018 Filed Sep 19, 2018 21:54 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,065 | $39.71 | $161,424.40 |
DisclosureSEC source: 0001567619-18-002900 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,051 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $39.50 to $39.90. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| September 18, 2018 Filed Sep 25, 2018 20:06 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,065 | $39.71 | $161,424.40 |
DisclosureSEC source: 0001567619-18-003090 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,051 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $39.50 to $39.90. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:48 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 2,788 | Not disclosed Strike: $40.54 | Not disclosed |
DisclosureSEC source: 0001140361-18-018962 · doc1.xml · derivative · entry 10 Karas Kevin R · CIK 0001522907 · Director · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 2,788 shares Expires 2027-01-04 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:48 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 3,410 | Not disclosed Strike: $34.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-018962 · doc1.xml · derivative · entry 9 Karas Kevin R · CIK 0001522907 · Director · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 3,410 shares Expires 2026-01-05 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:48 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 3,219 | Not disclosed Strike: $35.48 | Not disclosed |
DisclosureSEC source: 0001140361-18-018962 · doc1.xml · derivative · entry 8 Karas Kevin R · CIK 0001522907 · Director · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 3,219 shares Expires 2025-01-06 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:48 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 489 | Not disclosed Strike: $34.15 | Not disclosed |
DisclosureSEC source: 0001140361-18-018962 · doc1.xml · derivative · entry 7 Karas Kevin R · CIK 0001522907 · Director · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 489 shares Expires 2024-01-07 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:48 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 3,348 | Not disclosed Strike: $27.13 | Not disclosed |
DisclosureSEC source: 0001140361-18-018962 · doc1.xml · derivative · entry 6 Karas Kevin R · CIK 0001522907 · Director · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 3,348 shares Expires 2023-01-07 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:48 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 4,400 | Not disclosed Strike: $21.50 | Not disclosed |
DisclosureSEC source: 0001140361-18-018962 · doc1.xml · derivative · entry 5 Karas Kevin R · CIK 0001522907 · Director · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 4,400 shares Expires 2022-01-05 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:48 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingCommon Stock | 3,436 | $33.55 | $115,277.80 |
DisclosureSEC source: 0001140361-18-018962 · doc1.xml · nonDerivative · entry 4 Karas Kevin R · CIK 0001522907 · Director · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,116 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:48 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 7,392 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018962 · doc1.xml · nonDerivative · entry 3 Karas Kevin R · CIK 0001522907 · Director · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,552 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F2 · kind: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:48 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 2,355 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018962 · doc1.xml · nonDerivative · entry 2 Karas Kevin R · CIK 0001522907 · Director · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,160 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:48 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerClass B Common Stock | 2,355 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018962 · doc1.xml · nonDerivative · entry 1 Karas Kevin R · CIK 0001522907 · Director · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 20:23 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 11,617 | $0.00 Strike: $36.80 | $0.00 |
DisclosureSEC source: 0001140361-18-000812 · doc1.xml · derivative · entry 9 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,617 Underlying: Class A Common Stock · 11,617 shares Expires 2028-01-03 F7 · derivative.exercise_date: This option becomes fully exercisable on January 3, 2023. Read SEC document |
| January 04, 2017 Filed Jan 5, 2017 15:58 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 2,788 | $0.00 Strike: $40.54 | $0.00 |
DisclosureSEC source: 0001140361-17-000617 · doc1.xml · derivative · entry 14 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,788 Underlying: Class B Common Stock · 2,788 shares Expires 2027-01-04 F6 · derivative.exercise_date: This option becomes fully exercisable on January 4, 2022. Read SEC document |
| January 04, 2017 Filed Jan 5, 2017 15:58 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 16,728 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0001140361-17-000617 · doc1.xml · derivative · entry 8 Karas Kevin R · CIK 0001522907 · SVP Finance, CFO, Treas & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,728 Underlying: Class A Common Stock · 16,728 shares Expires 2027-01-04 F6 · derivative.exercise_date: This option becomes fully exercisable on January 4, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.